To report the efficacy of intravitreal injection of bevacizumab 1.25 mg (IVB) in the treatment of choroidal neovascularization (CNV) secondary to angioid streaks (AS).
Methods
Case review of two patients with CNV secondary to AS treated with three IVB with a 1-year follow-up.
Results
In both patients after 1 year fluorescein angiography and optical coherence tomography showed complete inactivity of the CNV and the ophthalmologic examination revealed stabilization of the visual acuity.
Conclusions
The IBV appeared to be an effective and safe treatment for CNV secondary to AS resulting in a long-term CNV inactivation. Further long-term studies in this type of lesion are desirable.
MenchiniU., VirgiliG., IntroiniU.Outcome of choroidal neovascularization in angioid streaks after photodynamic therapy. Retina2004; 24: 763–71.
3.
SpaideR.F., LaudK., FineH.F.Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age related macular degeneration. Retina2006; 26: 383–90.
4.
RinaldiM., Dell'OmoR., CostagliolaC.Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks. Arch Ophthalmol2007; 125: 1422–3.
5.
BhatnagarP., FreundK.B., SpaideR.F.Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum. Retina2007; 27: 897–902.
